MedWatch

Ambu fails to live up to revenue forecasts

The number of endoscopes sold is significantly higher than what the market had predicted in Ambu's second quarter. However, this has not brought about the kind of revenue that analysts had expected. The full-year outlook is maintained.

Photo: PR / Ambu

Ambu maintains its full-year outlook following a Q2 in which revenue totaled DKK 1bn.

However, the firm underperformed revenue-wise compared the DKK 1.016bn that analysts had expected. Ambu only provided DKK 1.001bn (USD 163.3m) in the second quarter of the company's staggered fiscal year. However, this is still progress compared to the DKK 989m from the same time period last year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs